ScreenerHero
DOCHealthpeak Properties, Inc.
NYSE · US · Real Estate · REIT - Healthcare Facilities · healthpeak.com
21.13USD+1.78%Mkt Cap: 14.72B $P/E: 59.31

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Healthpea…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$169.86BUSDP/E 105.2
VTR
Ventas, Inc.
$47.11BUSDP/E 167.0
OHI
Omega Healthcare Investors, Inc.
$14.80BUSDP/E 16.7
CTRE
CareTrust REIT, Inc.
$9.41BUSDP/E 24.9
HR
Healthcare Realty Trust Incorporated
$6.78BUSD
AED
Aedifica NV/SA
$6.20BUSDP/E 5.9
SBRA
Sabra Health Care REIT, Inc.
$5.25BUSDP/E 79.0
CSH-UN
Chartwell Retirement Residences
$5.06BUSDP/E 1054.0
NHI
National Health Investors, Inc.
$3.64BUSDP/E 21.4
PHP
Primary Health Properties Plc
$2.72BUSDP/E 16.1
MPT
Medical Properties Trust Inc. common stock
$2.48BUSD
LTC
LTC Properties, Inc.
$2.17BUSDP/E 14.4
DHC
Diversified Healthcare Trust
$1.96BUSD
SILA
Sila Realty Trust Inc. Common Stock
$1.68BUSDP/E 44.6
STRW
Strawberry Fields REIT Inc. Common Stock
$769.23MUSDP/E 20.9
NHP
National Healthcare Properties Inc. Class A Common Stock
$747.36MUSD
CPINV
Care Property Invest NV
$556.90MUSDP/E 8.0
UHT
Universal Health Realty Income Trust
$571.24MUSDP/E 29.6
XRN
Chiron Real Estate Inc. Common Stock
$533.88MUSDP/E 9.9
CHCT
Community Healthcare Trust Incorporated
$422.58MUSDP/E 22.1

Key Statistics

Company
Market Cap14.72B $
Enterprise Value24.95B $
Revenue (TTM)2.95B $
Gross Profit1.69B $
Net Income (TTM)71.35M $
Revenue/Share4.252 USD
Last Price21.13 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees411
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS42250P1030
Valuation
P/E (Trailing)59.31
P/E (Forward)-141.33
PEG4.32
EV/EBITDA15.88
EV/Revenue8.46
P/S5.10
P/B1.86
EPS (TTM)0.36
EPS (Forward)-0.15
52W Range
15.7075% of range22.95
52W High22.95 USD
52W Low15.70 USD
Profitability
Gross Margin60.00%
Oper. Margin15.99%
EBITDA Margin53.25%
Profit Margin2.53%
ROE0.95%
ROA0.35%
Growth
Revenue Growth11.10%
Earnings Growth68.20%
Cash Flow & Leverage
Operating CF1.25B $
CapEx (TTM)—
FCF Margin55.77%
FCF Yield11.18%
Net Debt8.68B $
Net Debt/EBITDA5.53
Balance Sheet
Debt/Equity1.35
Current Ratio2.29
Quick Ratio1.93
Book Value/Sh11.38 USD
Cash/Share2.380 USD
Dividends
Fwd Div Rate1.220 USD
Trail. Div Rate1.220 USD
Div. Yield5.88%
5Y Avg Yield5.57%
Payout Ratio348.58%
Ex-Div DateSep 14, 2026
Pay DateSep 25, 2026
Splits
Last Split1098:1000
Split DateNov 1, 2016
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.87 USD
Upside (mean)+8.2%
Target Range17.00 USD – 29.00 USD
$17.00+8.2% to mean$29.00
# Analysts19
Ownership
Shares Out.689.53M
Float686.69M
Insiders0.30%
Institutions97.76%
Short Interest
Short Ratio3.9d
Short % Float4.60%
Short % Out.3.54%
Shares Short24.39M
Short (prev mo.)27.14M
Technical
SMA 5021.36 (-1.1%)
SMA 20018.42 (+14.7%)
Beta1.00
S&P 52W Chg18.16%
Avg Vol (30d)4.27M
Avg Vol (10d)4.21M
Technical Indicators
RSI (14)41.8
MACD-0.2456
MACD Signal-0.0912
MACD Hist.-0.1544
BB Upper23.01 USD
BB Middle21.54 USD
BB Lower20.07 USD
BB Width13.63%
ATR (14)0.4511 USD
Vol Ratio (20d)0.53x